Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
|Articles|September 29, 2021
Pharmacy Clinical Pearl of the Day: Signs and Symptoms of Bipolar Disorder
Author(s)Saro Arakelians, PharmD
There are several types of bipolar disorders, including mania or hypomania and depression.
Advertisement
Clinical Pearl of the Day: Signs and Symptoms of Bipolar Disorder
Bipolar disorder is a mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression).
Explanation:
- There are several types of bipolar disorders, including mania or hypomania and depression.
- Bipolar I disorder: At least 1 manic episode that may be preceded or followed by hypomanic or major depressive episodes. In some cases, mania may trigger a break from reality (psychosis).
- Bipolar II disorder: At least 1 major depressive episode and at least 1 hypomanic episode, but no manic episodes.
- Cyclothymic disorder: At least 2 years—or 1 year in children and teenagers—of many periods of hypomania symptoms and periods of depressive symptoms.
- Treatment options: May include mood stabilizers such as lithium, valproic acid, divalproex sodium, carbamazepine, and lamotrigine; antipsychotics such as olanzapine, risperidone, quetiapine, aripiprazole, ziprasidone, and lurasidone; antidepressants and their combination with antipsychotics, such as Symbyax; and anti-anxiety medications, such as benzodiazepines.
Source:
Advertisement
Related to this article
About 89% of Americans live within 5 miles of a pharmacy, but proximity says little about whether they can afford their medications or get real counseling.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Getting patients vaccinated matters more than which COVID-19 vaccine they receive, says Jodi Longueil, PharmD.
The new agreement lets Hims & Hers patients obtain FDA-approved tirzepatide and orforglipron at Lilly’s self-pay prices.
The approval is supported by findings from the phase 3 OCEANIC-STROKE trial.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Christie Ballantyne, MD, explains how the CORALreef Extension study adds safety exposure and shows LDL-C lowering with oral enlicitide is sustained over time.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
3
The Most Accessible Healthcare Professional—But Accessible to Whom?
4
FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumor
5